Olmesartan Medoxomil Accord

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil Accord, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is used to manage high blood pressure in adult patients. GNH USA supplies Olmesartan Medoxil Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxil Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Medoxil is an ARB that lowers blood pressure by blocking the renin‑angiotensin system.

- Hypertension: helps lower systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.

Olmesartan Medoxil Accord may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Headache - Fatigue - Upper respiratory tract infection - Nausea

Serious or Rare Side Effects: - Angio‑ema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver function abnormalities

When using Olmesartan Medoxil Accord, consider the following safety measures:

- Monitor blood pressure: regularly check to ensure therapeutic effect. - Assess renal function: evaluate kidney function before initiation and periodically thereafter. - Check electrolytes: especially potassium levels, to avoid hyper‑kalaemia. - Avoid in pregnancy: drug should be discontinued if pregnancy is confirmed. - Store at ambient temperature: keep below 25°C, protect from moisture and keep in original packaging.

OlmesAR​d​  

Major Interactions (​Avoid ): 

   ");